The transformative impact of a historic AI infrastructure investment on the drug discovery and healthcare sectors is becoming increasingly evident. This $500 billion investment, spearheaded by Stargate—a collaborative venture between OpenAI, SoftBank, and Oracle—aims to fast-track breakthroughs in p
The University of Chicago Medicine (UChicago Medicine) has initiated a Phase 2 clinical trial to explore the potential of CAR T-cell therapy in treating three challenging autoimmune diseases: systemic lupus erythematosus, inflammatory myositis, and systemic sclerosis. CAR T-cell therapy, originally
Precision medicine represents an innovative approach to disease treatment and prevention that is biomarker-guided and individualized. It incorporates an individual's genetic information along with other social health determinants such as environment and lifestyle. This approach enables
Recent advancements in cancer research have brought to light exciting new possibilities in the realm of immunotherapy, particularly concerning pancreatic cancer. Led by Dr. Vinod Balachandran, a team at Memorial Sloan Kettering Cancer Center (MSK) has made groundbreaking discoveries related to the
The Perelman School of Medicine at the University of Pennsylvania has introduced a revolutionary tool named MISO (Multi-modal Spatial Omics), which leverages artificial intelligence to significantly improve the detection and analysis of cell-level characteristics in cancer. This innovative tool
A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco
